Lipidomics of cyclophosphamide 4-hydroxylation in patients receiving post-transplant cyclophosphamide.

Navarro, Sandi L; Zheng, Zihan; Randolph, Timothy W; Nakamura, Ryotaro; Sandmaier, Brenda M; Hockenbery, David; McCune, Jeannine S

Navarro, Sandi L; Zheng, Zihan; Randolph, Timothy W; Nakamura, Ryotaro; Sandmaier, Brenda M; Hockenbery, David; McCune, Jeannine S.

Afiliación

Navarro SL; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Zheng Z; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Randolph TW; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Nakamura R; Department of Hematologic Malignancies Translational Sciences, City of Hope, Duarte, California, USA.
Sandmaier BM; Department of Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California, USA.
Hockenbery D; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
McCune JS; Department of Medicine, University of Washington, Seattle, Washington, USA.

Clin Transl Sci ; 15(11): 2772-2780, 2022 11.

Article en En | MEDLINE | ID: mdl-36088654

Asunto(s)

Trasplante de Células Madre Hematopoyéticas; Humanos; Lipidómica; Hidroxilación; Ciclofosfamida/efectos adversos; Lípidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas Límite: Humans Idioma: En Revista: Clin Transl Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google